20Med Therapeutics Appoints Industry Veteran Hugo Fry as Chief Business Officer
Leiden, The Netherlands, November 29, 2023 – 20Med Therapeutics, a leader in non-viral delivery of mRNA vaccines, today announced the...
20Med Therapeutics Appoints Industry Veteran Hugo Fry as Chief Business Officer
Come & meet us at JPM24!
Come & meet us!
20Med Therapeutics and Touchlight to collaborate on novel vaccine delivery platform project
20Med Therapeutics and CEPI Sign Agreement to Advance ThermoStable Vaccines Technology
20Med Therapeutics to Participate in the New Cancer Research Consortium Oncode-PACT
20Med Therapeutics started research into mRNA vaccines against variants of the SARS-CoV-2 virus